Femoropopliteal bypass using polytetrafluoroethylene

Area of Science:

• Vascular Surgery
• Biomaterials Science

Background:

• Femoropopliteal bypass grafting is crucial for treating peripheral artery disease.
• Reinforced expanded polytetrafluoroethylene (ePTFE) grafts are utilized as alternatives to autogenous vein grafts.
• Evaluating the long-term efficacy of ePTFE in femoropopliteal reconstructions is essential.

Purpose of the Study:

• To assess the clinical outcomes and patency rates of reinforced ePTFE grafts in femoropopliteal bypass surgery.
• To compare the performance of ePTFE grafts with historical data from autogenous vein grafts.

Main Methods:

• A retrospective analysis of 37 femoropopliteal bypass operations using reinforced ePTFE grafts in 31 patients.
• Indications included intermittent claudication, severe ischemia (rest pain or gangrene), and prophylactic aneurysm treatment.
• One-year cumulative patency rates were calculated and compared between different patient groups and with autogenous vein graft data.

Main Results:

• One-year cumulative patency rates were 75% for intermittent claudication and 20% for severe ischemia.
• Three cases of graft thrombosis in claudication patients resulted in amputation despite thrombectomy.
• Autogenous vein grafts demonstrated superior one-year patency rates (80% for claudication, 70% for severe ischemia).

Conclusions:

• Reinforced ePTFE femoropopliteal bypass grafts exhibit suboptimal patency rates, particularly in patients with severe ischemia.
• Autogenous vein grafts remain the preferred option due to significantly better long-term patency and lower complication rates.
• The use of ePTFE grafts in this setting warrants careful consideration due to potential for graft failure and adverse outcomes.